Development of pressure overload induced cardiac hypertrophy is unaffected by long term treatment with losartan

Molecular and Cellular Biochemistry

Volumn 188, Issue 1-2, 1998, Pages 225-233

  Turcani, Marian ^a   Rupp, Heinz ^b  

^a Physics and Informatics   (Slovakia)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angiotensin II receptor antagonist; Heart hypertrophy; Losartan; Myosin isozymes; Pressure overload; Ventricular function

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; HYDROXYPROLINE; ISOENZYME; LOSARTAN; MYOSIN; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; BLOOD PRESSURE; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VOLUME; MALE; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ADMINISTRATION, ORAL; ANIMALS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MYOCARDIAL CONTRACTION; ORGAN SIZE; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

ANIMALIA;

EID: 0031757520     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006867227556     Document Type: Conference Paper

References (48)

1. Schwartz K, Bouveret P, Bercovici J, Swynghedauw B: An immunochemical difference between myosins from normal and hypertrophied rat hearts. FEBS Lett 93: 137-139, 1978
2. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K: Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy: Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 79: 970-977, 1987
3. Chien KR, Knowlton KU, Zhu H, Chien S: Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J 5: 3037-3046, 1991
4. Schwartz K, Carrier L, Mercadier JJ, Lompre AM, Boheler KR: Molecular phenotype of the hypertrophied and failing myocardium. Circulation 87 (Suppl. VII): VII-5-VII-10, 1993
5. Lompré AM, Anger M, Levitsky D: Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: Function and gene expression. J Mol Cell Cardiol 26: 1109-1121, 1994
6. Feldman AM, Weinberg EO, Ray PE, Lorell BH: Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73: 184-192, 1993
7. Goldberg MR, Tanaka W, Barchowsky A, Bradstreet TE, McCrea J, Lo MW, McWilliams EJ, Bjomsson TD: Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Hypertension 21: 704-713, 1993
8. Campbell DJ, Kladis A, Valentijn AJ: Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyime. J Cardiovasc Pharm 26: 233-240, 1995
9. Levy BI, Benessian J, Henrion D, Caputo L, Hcymes C, Diurez M, Poitevin P, Samuel JL: Chronic blockade of AT,-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 98: 418-425, 1996
10. 1 receptor inhibition. Effects on hypertrophie remodelling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation 95: 1592-1600, 1997
11. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Drexler H: Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in rats. Circulation 89: 2273-2282, 1994
12. Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JFM, Apstein CS, Lorell BH: Distribution and functional significance of cardiac ACE in hypertrophied rat hearts. Circulation 87: 1328-1339, 1993
13. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 69: 475-482, 1991
14. Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, Kromer HP, Riegger GAJ, Schunkert H: Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 25: 250-259, 1995
15. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type A1) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73: 439-447, 1993
16. Kabour A, Henegar JR, Janicki JS: Angiotensin II (AII)-induced myocyte necrosis: Role of the All receptor. J Cardiovasc Pharm 23: 547-553, 1994
17. Kromer HP, Riegger GAJ: Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol 62: 161-163, 1988
18. Kromer EP, Elsner D, Riegger GAJ: Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. Am J Hypertens 4: 521-524, 1991
19. Zierhut W, Zimmer HG, Gerdes AM: Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 69: 609-617, 1991
20. Golomb E, Abassi ZA, Cuda G, Stylianou M, Panchal VR, Trachevsky D, Keiser HR: Angiotensin H, maintains, but does not mediate isoproterenol-induced cardiac hypertrophy in rats. Am J Physiol 267: H1496-H1506, 1994
21. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 17: 257-264, 1997
22. Grossman W: Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med 69: 576-584, 1980
23. Koide M, Nagatsu M, Zile M, Hamawaki M, Swindle NIM, Keech G, DeFreyte G, Tagawa H, Cooper IV G, Carabello BA: Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95: 1601-1610, 1997
24. Penncock GD, Raya TE, Bahl JJ, Goldman S, Morkin E: Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid (DITPA): A new approach to improving left ventricular performance in heart failure. Circulation 88: 1289-1298, 1993
25. Turcani M, Rupp H: Etomoxir improves left ventricular performance of pressure-overloaded rat heart. Circulation 96: 3691-3686, 1997
26. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosteron system. Circulation 83: 1849-1865, 1991
27. Brilla CG, Rupp H, Funck R, Maisch B: The renin-angiotensin-aldosterone system and myocardial collagen matrix remodeling in congestive heart failure. Eur Heart J 16 (Suppl. O): 107-109, 1995
28. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS: Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 91: 2642-2654, 1995
29. Jacob R, Brandle M, Dierberger B, Ross Ch: Conceptional and methodological basis for the evaluation of ventricular and myocardial mechanics. In: R. Jacob (ed.). Evaluation of Cardiac Contractility. Gustav Fischer, Stuttgart/New York, NY, 1987, pp 75-100
30. Hepp A, Hansis M, Gülch R, Jacob R: Left ventricular isovolumetric pressure-volume relations, 'diastolic tone', and contractility in the heart after physical training. Basic Res Cardiol 69: 517-531, 1974
31. Jacob R, Dieberger B, Gülch RW, Noma K: Adaptive alterations in cardiac mass and configuration: beneficial or detrimental? A quantitative analysis based on the finite-element method. In: M. Nagano, N. Takeda, and N.S. Dhalla (eds). The Adapted Heart. Raven Press, New York, NY, 1994, pp 111-123
32. Sandler H, Dodge HT: Left ventricular tension and stress in man. Circ Res 13: 91-104, 1963
33. Rupp H, Wahl R, Hansen M: Influence of diet and carnitine palmitoyl-transferase I inhibition on myosin and sarcoplasmic reticulum. J Appl Physiol 72: 352-360, 1992
34. Stegemann, H: Mikrobestimmung von Hydroxyprolin mit Chloramin T und p-Dimethylaminobenzaldehyd. Hoppe-Seylers Z Physiol Chem 311: 41-45, 1958
35. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH: Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 90: 1410-1422, 1994
36. Rockman HA, Wachhorst SP, Mao L, Ross J Jr: ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 266: 112468-112475, 1994
37. 1, expression. Hypertension 23: 587-592, 1994
38. Ishiye M, Umemura K, Uematsu T, Nakashima M: Angiotensin AT, receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin. Eur J Phannacol. 280: 11-17, 1995
39. Sadoshima J, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes an hyperplasia of cardiac fibroblasts: Critical role of the AT, receptor subtype. Circ Res 73: 413-423, 1993
40. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Marumo F, Hiroe M: Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92: 398-403, 1993
41. Ruzicka M, Leenen FHH: Renin-angiotensin system and volume overload-induced cardiac remodeling. In: N.S. Dhalla, R.E. Beamish, N. Takeda and M. Nagano (eds). The Failing Heart. Lippincott-Raven Publishers, Philadelphia, 1995, pp 305-325
42. Lee KR, MacFadyen RJ, Doing JK, Reid JL: Role of angiotensin in the extravascular system. J Hum Hypertens 7 (Suppl. 2): S7-S12, 1993
43. Sucic D, Nunez E, Frohlich Ed, Prakash O: Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension 28: 265-268, 1996
44. Rupp H, Wahl R, Hansen M: Influence of diet and carnitine palmitoyl-transferase I inhibition on myosin and sarcoplasmic reticulum. J Appl Physiol 72: 352-360, 1992
45. Vetter R, Rupp H: CPT- 1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins. Am J Physiol 267: H2091-H2099, 1994
46. Zarain-Herzberg A, Rupp H, Elimban V, Dhalia NS: Modification of sarcoplasmic reticulum gene expression in pressure overloaded cardiac hypertrophy by etomoxir. FASEB J 10: 1303-1309, 1996
47. Crawford DC, Chobanian AV, Brecher P: Angiotensin II induces fibonectin expression associated with cardiac fibrosis in the rat. Circ Res 74: 727-739, 1994
48. Pickering JG, Bougimer DR: Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis. Circulation 81: 949-958, 1990